Advisornet Financial’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,825
Closed -$39K 1694
2018
Q4
$39K Sell
1,825
-300
-14% -$6.86K 0.01% 747
2018
Q3
$54K Sell
2,125
-775
-27% -$19.7K 0.01% 698
2018
Q2
$73K Buy
2,900
+310
+12% +$7.66K 0.01% 609
2018
Q1
$64K Buy
2,590
+1,990
+332% +$51.1K 0.01% 636
2017
Q4
$15K Buy
+600
New +$15.2K ﹤0.01% 934

Other funds holding LDRS

Advisornet Financial's LDRS Position: Q1 2019 in Review

Advisornet Financial sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q1 2019, closing a stake of 1,825 shares — an estimated $39K sold.

Advisornet Financial first reported a position in LDRS in Q4 2017 and held it in 5 quarters. The position peaked at $73K in Q2 2018. 11 funds tracked by Wall St. Rank hold LDRS as of Q1 2019.

  • Advisornet Financial reported no remaining Innovator IBD ETF Leaders ETF position as of Q1 2019 after selling out during the quarter.
  • Advisornet Financial sold 1,825 Innovator IBD ETF Leaders ETF shares in Q1 2019, an estimated $39K.
  • Advisornet Financial first reported a position in Innovator IBD ETF Leaders ETF in Q4 2017 and held it in 5 quarters.
  • Advisornet Financial's Innovator IBD ETF Leaders ETF position peaked at $73K in Q2 2018.
  • 11 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q1 2019.

Based on Advisornet Financial's 13F filing for Q1 2019, filed 14 May 2019.